Wolbink, G.J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

Bart JF van den Bemt, Alfons A den Broeder, GJ Wolbink, Yechiel A Hekster, Piet LCM van Riel, Bart Benraad, Frank HJ van den Hoogen

Journal:

BMC Musculoskeletal Disorders

Year:

2011

Language:

english

File:

PDF, 420 KB

english, 2011

2

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study

Aatke van der Maas, Bart JF van den Bemt, Gertjan Wolbink, Frank HJ van den Hoogen, Piet LCM van Riel, Alfons A den Broeder

Journal:

BMC Musculoskeletal Disorders

Year:

2012

Language:

english

File:

PDF, 162 KB

english, 2012

3

Stoïcijns coachen

Journal:

Supervisie en Coaching

Year:

2011

Language:

dutch

File:

PDF, 209 KB

dutch, 2011

4

Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study

J. Pijpe, G. W. van Imhoff, F. K. L. Spijkervet, J. L. N. Roodenburg, G. J. Wolbink, K. Mansour, A. Vissink, C. G. M. Kallenberg, H. Bootsma

Journal:

Arthritis & Rheumatism

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

5

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population

Hooijberg, Femke, Boekel, Laura, Vogelzang, Erik H, Leeuw, Maureen, Boers, Maarten, van Vollenhoven, Ronald, Lems, Willem F, Nurmohamed, Mike T, Wolbink, Gertjan

Journal:

The Lancet Rheumatology

Year:

2020

File:

PDF, 135 KB

2020

6

Differential effect of drug interference in immunogenicity assays

Margreet H. Hart, Henk de Vrieze, Diana Wouters, Gerrit-Jan Wolbink, Joep Killestein, Els R. de Groot, Lucien A. Aarden, Theo Rispens

Journal:

Journal of Immunological Methods

Year:

2011

Language:

english

File:

PDF, 2.27 MB

english, 2011

7

Drug interference in immunogenicity assays depends on valency

Rispens, Theo, Hart, Margreet H., Ooijevaar-de Heer, Pleuni, van Leeuwen, Astrid, Vennegoor, Anke, Killestein, Joep, Wolbink, Gerrit-Jan, van der Kleij, Desiree

Journal:

Journal of Pharmaceutical and Biomedical Analysis

Year:

2013

Language:

english

File:

PDF, 1.57 MB

english, 2013

8

Relation entre la concentration plasmatique de certolizumab pegol et l’amélioration de l’activité de la maladie dans la polyarthrite rhumatoïde et la maladie de Crohn

Goupille, P., Wolbink, G., Sandborn, W., Marotte, H., Mulleman, D., Ternant, D., Paul, S., De Longueville, M., Casteele, N. Vande, Zamacona, M., O'brien, C., Kvien, T.K., Arthur, K.

Journal:

Revue du Rhumatisme

Year:

2016

Language:

french

File:

PDF, 833 KB

french, 2016

9

Inhibition of human complement by β-glycyrrhetinic acid

B. H. KROES, C. J. BEUKELMAN, A. J. J. VAN DEN BERG, G. J. WOLBINK, H. VAN DIJK, R. P. LABADIE

Journal:

Year:

1997

Language:

english

File:

PDF, 472 KB

english, 1997

10

Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction

Sacha Zeerleder, C. Erik Hack, Christoph Caliezi, Gerard van Mierlo, Anke Eerenberg-Belmer, Angela Wolbink, Walter A. Wuillenmin

Journal:

Clinical Immunology

Year:

2005

Language:

english

File:

PDF, 220 KB

english, 2005

11

Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation

Merel C.M. Strik, Pieter J.A. de Koning, Monique J. Kleijmeer, Bellinda A. Bladergroen, Angela M. Wolbink, Janice M. Griffith, Dorine Wouters, Yoshihiro Fukuoka, Lawrence B. Schwartz, C. Erik Hack, S.

Journal:

Molecular Immunology

Year:

2007

Language:

english

File:

PDF, 1.42 MB

english, 2007

12

Functional Analysis of the Anti-adalimumab Response Using Patient-derived Monoclonal Antibodies

van Schouwenburg, P. A., Kruithof, S., Votsmeier, C., van Schie, K., Hart, M. H., de Jong, R. N., van Buren, E. E. L., van Ham, M., Aarden, L., Wolbink, G., Wouters, D., Rispens, T.

Journal:

Journal of Biological Chemistry

Year:

2014

Language:

english

File:

PDF, 1.48 MB

english, 2014

13

The minipig as an alternative non-rodent model for immunogenicity testing using the TNFα blockers adalimumab and infliximab

van Mierlo, Geertje J. D., Cnubben, Nicole H. P., Wouters, Diana, Wolbink, Gerrit Jan, Hart, Margreet H. L., Rispens, Theo, Ganderup, Niels-Christian, Kuper, C. Frieke, Aarden, Lucien, Penninks, André

Journal:

Journal of Immunotoxicology

Year:

2014

Language:

english

File:

PDF, 341 KB

english, 2014

14

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Oral Presentations - OP0025 Antidrug antibodies detection is strongly influenced by the type of assay used

Ruwaard, J, Marsman, AF, Nurmohamed, MT, Velthuis, H te, Bloem, K, Rispens, T, Wolbink, GJ

Language:

english

File:

PDF, 140 KB

english

15

A7.14 Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

de Jong, TD, Vosslamber, S, Blits, M, Wolbink, G, Nurmohamed, MT, van der Laken, CJ, Jansen, G, Mantel, E, Lübbers, J, de Ridder, S, Voskuyl, AE, Verweij, CL

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 67 KB

english, 2015

16

Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases

Papamichael, Konstantinos, Vogelzang, Erik, Lambert, Jo, Wolbink, Gertjan, Cheifetz, Adam S.

Journal:

Expert Review of Clinical Immunology

Year:

2019

Language:

english

File:

PDF, 1.11 MB

english, 2019

17

The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells

Bellinda A. Bladergroen, Merel C. M. Strik, Angela M. Wolbink, Dorine Wouters, Roel Broekhuizen, J. Alain Kummer, C. Erik Hack

Journal:

European Journal of Immunology

Year:

2005

Language:

english

File:

PDF, 297 KB

english, 2005

18

Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody

Theo Rispens, Astrid van Leeuwen, Anke Vennegoor, Joep Killestein, Rob C. Aalberse, Gerrit J. Wolbink, Lucien A. Aarden

Journal:

Analytical Biochemistry

Year:

2011

Language:

english

File:

PDF, 322 KB

english, 2011

19

P039 DOES IMMUNOGENICITY PLAY A ROLE IN ADALIMUMAB TREATMENT FOR CROHN'S DISEASE?

R.L. West, Z. Zelinkova, G.J. Wolbink, E.J. Kuipers, P.C.F. Stokkers, C.J. van der Woude

Journal:

Journal of Crohn's and Colitis Supplements

Year:

2008

Language:

english

File:

PDF, 73 KB

english, 2008

20

Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis

Bos, W H, Bartelds, G M, Vis, M, van der Horst, A R, Wolbink, G J, van de Stadt, R J, van Schaardenburg, D, Dijkmans, B A C, Lems, W F, Nurmohamed, M T, Aarden, L, Hamann, D

Journal:

Annals of the Rheumatic Diseases

Year:

2009

Language:

english

File:

PDF, 268 KB

english, 2009

21

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Vennegoor, A., Rispens, T., Strijbis, E. M., Seewann, A., Uitdehaag, B. M., Balk, L. J., Barkhof, F., Polman, C. H., Wolbink, G., Killestein, J.

Journal:

Multiple Sclerosis Journal

Year:

2013

Language:

english

File:

PDF, 750 KB

english, 2013

22

Expression of Granzyme B during Primary Cytomegalovirus Infection after Renal Transplantation

Peter C. Wever, Liesbeth H. A. Spaeny, Hans J. J. van der Vliet, Rob J. Rentenaar, Angela M. Wolbink, Janto Surachno, Pauline M. E. Wertheim, Peter T. A. Schellekens, C. Erik Hack and Ineke J. M. ten

Journal:

The Journal of Infectious Diseases

Year:

1999

Language:

english

File:

PDF, 922 KB

english, 1999

23

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant Interleukin-2

Baars, JW, Hack, CE, Wagstaff, J, Eerenberg-Belmer, AJM, Wolbink, GJ, Thijs, LG, Strack van Schijndel, RJM, van der Vall, HLJA, Pinedo, HM

Journal:

British Journal of Cancer

Year:

1992

Language:

english

File:

PDF, 1.22 MB

english, 1992

24

THU0510 Igg ACPA Level Increase Drives Rheumatoid Factor Response Maturation in Patients before Onset of Clinically Apparent Rheumatoid Arthritis

Falkenburg, W., Bos, W.H., Sohrabian, A., Rönnelid, J., Wolbink, G., van Schaardenburg, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 146 KB

english, 2014

25

SAT0397 Comparison of Long-Term Drug Survival Outcome with Etanercept Treatment and Adalimumab Treatment of Ankylosing Spondylitis

Ruwaard, J., l'Ami, M., Marsman, A., Kneepkens, E., van der Horst-Bruinsma, I.E., van Denderen, C., Nurmohamed, M.T., Wolbink, G.

Journal:

Annals of the Rheumatic Diseases

Year:

2016

Language:

english

File:

PDF, 94 KB

english, 2016

26

Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy

Ruwaard, Jill, van der Vlugt, Eva R., Wolbink, Gertjan

Journal:

The Journal of Rheumatology

Year:

2018

Language:

english

File:

PDF, 179 KB

english, 2018

27

Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B

Willemijn B. Breunis, Edwin van Mirre, Judy Geissler, Nadja Laddach, Gertjan Wolbink, Ellen van der Schoot, Masja de Haas, Martin de Boer, Dirk Roos, Taco W. Kuijpers

Journal:

Year:

2009

Language:

english

File:

PDF, 389 KB

english, 2009

28

Interplay of complement and cytokines in the pathogenesis of septic shock

Jan Paul de Boer, Gert-Jan Wolbink, Lambertus G. Thijs, Johanna W. Baars, John Wagstaff, C.Erik Hack

Journal:

Immunopharmacology

Year:

1992

Language:

english

File:

PDF, 1.43 MB

english, 1992

29

P500 Fecal loss of infliximab as a cause of lack of response in severe inflammatory bowel disease

Brandse, J.F., Wildenberg, M.E., de Bruyn, J.R., Wolbink, G., Lowenberg, M., Ponsioen, C.Y., van den Brink, G.R., D'Haens, G.R.A.M.

Journal:

Journal of Crohn's and Colitis

Year:

2013

Language:

english

File:

PDF, 55 KB

english, 2013

30

Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

Vogelzang, E. H., Kneepkens, E. L., Nurmohamed, M. T., van Kuijk, A. W. R., Rispens, T., Wolbink, G., Krieckaert, C. L. M.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 629 KB

english, 2014

31

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor expression in the synovium

Wijbrandts, C A, Dijkgraaf, M G W, Kraan, M C, Vinkenoog, M, Smeets, T J, Dinant, H, Vos, K, Lems, W F, Wolbink, G J, Sijpkens, D, Dijkmans, B A C, Tak, P P

Journal:

Annals of the Rheumatic Diseases

Year:

2008

Language:

english

File:

PDF, 234 KB

english, 2008

32

A1.45 Hyperglycosylation of ACPA-IGG variable domains modulates reactivity to citrullinated antigens

Rombouts, Y, Willemze, A, van Beers, J J B C, Shi, J, Kerkman, P F, Janssen, G M C, van Veelen, P A, Zaldumbide, A, Hoeben, R C, Pruijn, G J, Deelder, A M, Wolbink, G, Rispens, T, García-Vallejo, J J,

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 52 KB

english, 2014

33

Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms

G. M. Bartelds, C. A. Wijbrandts, M. T. Nurmohamed, G. J. Wolbink, N. de Vries, P. P. Tak, B. A. C. Dijkmans, J. B. A. Crusius, I. E. vand der Horst-Bruinsma

Journal:

Arthritis & Rheumatism

Year:

2009

Language:

english

File:

PDF, 67 KB

english, 2009

34

Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti–tumor necrosis factor treatment in ankylosing spondylitis

Mirjam K. de Vries, Izhar C. van Eijk, Irene E. van der Horst-bruinsma, Mike J. L. Peters, Michael T. Nurmohamed, Ben A. C. Dijkmans, Bouke P. C. Hazenberg, Gerrit J. Wolbink

Journal:

Arthritis Care & Research

Year:

2009

Language:

english

File:

PDF, 133 KB

english, 2009

35

COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2

Thijs, LambertusG., Hack, C.Erik, Strack Van Schijndel, RobertJ.M., Nuijens, JanH., Jan Wolbink, Gert, Eerenberg-Belmer, AnkeJ.M., Van Der Vall, Henry, Wagstaff, John

Journal:

Year:

1989

Language:

english

File:

PDF, 156 KB

english, 1989

36

Reduction of Circulating Secretory Phospholipase A 2 Levels by Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody in Patients with Severe Crohn's Disease

H. M. van Dullemen, G. J. Wolbink,,

Journal:

Scandinavian Journal of Gastroenterology

Year:

1998

Language:

english

File:

PDF, 79 KB

english, 1998

37

Immunogenicity of biological therapeutics

Krieckaert, Charlotte, Rispens, Theo, Wolbink, Gertjan

Journal:

Current Opinion in Rheumatology

Year:

2012

Language:

english

File:

PDF, 204 KB

english, 2012

38

The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels

Bos, W H, Ursum, J, de Vries, N, Bartelds, G M, Wolbink, G J, Nurmohamed, M T, van der Horst-Bruinsma, I E, van de Stadt, R J, Crusius, J B A, Tak, P P, Dijkmans, B A C, van Schaardenburg, D

Journal:

Annals of the Rheumatic Diseases

Year:

2007

Language:

english

File:

PDF, 180 KB

english, 2007

39

Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study

Peters, M. J. L., Welsh, P., McInnes, I. B., Wolbink, G., Dijkmans, B. A. C., Sattar, N., Nurmohamed, M. T.

Journal:

Annals of the Rheumatic Diseases

Year:

2010

Language:

english

File:

PDF, 153 KB

english, 2010

40

THU0243 A Concentration-Effect Curve of Adalimumab in Ankylosing Spondylitis Patients; Does it Exist or Not?

Marsman, A., Kneepkens, E., Ruwaard, J., Cheng-Chung Wei, J., Rispens, T., Nurmohamed, M., van Denderen, C., van der Horst-Bruinsma, I., Wolbink, G.

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 73 KB

english, 2015

41

OP0149 Evaluating the cost-effectiveness of personalized treatment with adalimumab using serum drug level and anti-adalimumab antibodies in rheumatoid arthritis patients

Krieckaert, C., Nair, S.C., Nurmohamed, M.T., van Dongen, C.J., Lems, W.F., Lafeber, F.P., Bijlsma, J.W., Wolbink, G., Welsing, P.M.

Journal:

Annals of the Rheumatic Diseases

Year:

2013

Language:

english

File:

PDF, 53 KB

english, 2013

42

Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity

Krieckaert, Charlotte L., Jamnitski, Anna, Nurmohamed, Michael T., Kostense, Piet J., Boers, Maarten, Wolbink, Gertjan

Journal:

Arthritis & Rheumatism

Year:

2012

Language:

english

File:

PDF, 113 KB

english, 2012

43

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study

Bos, W. H., Wolbink, G. J., Boers, M., Tijhuis, G. J., de Vries, N., van der Horst-Bruinsma, I. E., Tak, P. P., van de Stadt, R. J., van der Laken, C. J., Dijkmans, B. A. C., van Schaardenburg, D.

Journal:

Annals of the Rheumatic Diseases

Year:

2010

Language:

english

File:

PDF, 164 KB

english, 2010

44

Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up

Kneepkens, E. L., Krieckaert, C. L. M., van der Kleij, D., Nurmohamed, M. T., van der Horst-Bruinsma, I. E., Rispens, T., Wolbink, G. J.

Journal:

Annals of the Rheumatic Diseases

Year:

2014

Language:

english

File:

PDF, 449 KB

english, 2014

45

Search for a concentration–effect curve of adalimumab in ankylosing spondylitis patients

Marsman, AF, Kneepkens, EL, Ruwaard, J, Wei, JC, Nurmohamed, MT, van Denderen, C, van der Horst-Bruinsma, IE, Rispens, T, Wolbink, G

Journal:

Scandinavian Journal of Rheumatology

Year:

2016

Language:

english

File:

PDF, 416 KB

english, 2016

46

Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab

Ruwaard, J, l’Ami, MJ, Marsman, AF, Kneepkens, EL, van Denderen, JC, van der Horst-Bruinsma, IE, Nurmohamed, MT, Wolbink, G

Journal:

Scandinavian Journal of Rheumatology

Year:

2017

Language:

english

File:

PDF, 408 KB

english, 2017

47

THU0208 Efficacy of Switching Tumor Necrosis Factor α Inhibitor to a Second Tumor Necrosis Factor α Inhibitor and the Influence of Drug Levels and Anti-Drug Antibodies in Patients with Ankylosing Spondylitis and Psoriatic Arthritis

Ruwaard, J., Kneepkens, E., Marsman, A., Vogelzang, E., van der Horst-Bruinsma, I.E., Rispens, T., Nurmohamed, M.T., Wolbink, G.

Journal:

Annals of the Rheumatic Diseases

Year:

2015

Language:

english

File:

PDF, 141 KB

english, 2015

48

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13â16 June 2018 - ()] Saturday, 16 JUNE 2018 - SAT0211âIs there a potential for therapeutic drug monitoring of subcutaneous tocilizumab in patients with rheumatoid arthritis in daily practice?

Layegh, Z., `Ami, M. J. L, Bastida, C., Huitema, A. D., Krieckaert, C., Nurmohamed, M. T., Rispens, T., Wolbink, G.

File:

PDF, 318 KB

49

A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells

C.Erik Hack, Gert-Jan Wolbink, Caspar Schalkwijk, Han Speijer, Willem Th. Hermens, Henk van den Bosch

Journal:

Immunology Today

Year:

1997

Language:

english

File:

PDF, 323 KB

english, 1997

50

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis

van der Laken, C J, Voskuyl, A E, Roos, J C, Stigter van Walsum, M, de Groot, E R, Wolbink, G, Dijkmans, B A C, Aarden, L A

Journal:

Annals of the Rheumatic Diseases

Year:

2006

Language:

english

File:

PDF, 346 KB

english, 2006

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски